Expanding number of life science and research-based associations worldwide has accounted high number of innovative work exercises, this has added to the developing interest for catalysts and reagents. Increasing utilization of these proteins and reagents in biotechnology and pharmaceutical organizations and scholarly foundations have brought about an expansion sought after for better than ever items, which will additionally add to this current market’s development. Additionally, government activities in biotechnology industry will support the request from this market, subsequently this will add to the development sought after for atomic science catalysts, units and reagents. Some of the real driving variables for the development of this market incorporate expanding innovative work exercises in biotechnology research and medication disclosure, rising number of uses for these proteins and reagents and expanding interest for as good as ever chemicals and reagents.
How Big is the Global Molecular Biology Enzymes and Kits & Reagents Market?
The Molecular Biology Enzymes and Kits & Reagents Market is expected to be around US$ 32 Billion by 2028 at a CAGR of 17.1% in given forecast period.
The major driving factors of Molecular Biology Enzymes and Kits & Reagents Market are as follows:
The restraining factors of Molecular Biology Enzymes and Kits & Reagents Market are as follows:
The Molecular Biology Enzymes and Kits & Reagents Market is segmented on the lines of its application, product, end user and regional. Based on application segmentation it covers PCR, sequencing, cloning, epigenetics, restriction digestion, synthetic biology, other applications. Based on product segmentation it covers kits & reagents, enzymes. Based on end user segmentation it covers academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, other end users. The Molecular Biology Enzymes and Kits & Reagents Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Molecular Biology Enzymes and Kits & Reagents Market and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for Molecular Biology Enzymes and Kits & Reagents Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Molecular Biology Enzymes and Kits & Reagents Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Inc. (U.S.), Merck KGaA (Germany), New England Biolabs, Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Becton, Dickinson and Company (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), and Takara Bio, Inc. (Japan).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Molecular Biology Enzymes and Kits & Reagents Markethas been segmented as below: (Accordingly)
By Application Analysis:
By Product Analysis:
By End User Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Molecular Biology Enzymes and Kits & Reagents Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Molecular Biology Enzymes and Kits & Reagents Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Molecular Biology Kits Market: Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study
3 Molecular Biology Kits Market: Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Molecular Biology Enzymes and Kits & Reagents: Market Overview (2018-2024)
4.2 Geographic Analysis: Molecular Biology Enzymes and Kits & Reagents Market, By End User
4.3 Molecular Biology Enzymes and Kits & Reagents Market, By Product
4.4 Molecular Biology Enzymes and Kits & Reagents Market, By Application
4.5 Molecular Biology Enzymes and Kits & Reagents Market, By End User
4.6 Geographic Snapshot of the Molecular Biology Enzymes and Kits & Reagents Market
5 Molecular Biology Kits Market: Market Overview
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Technological Advancements in the Life Sciences Industry
5.1.1.2 Increased Research Activities in the Pharmaceutical and Biotechnology Sectors
5.1.1.3 Rising Incidence of Infectious Diseases and Genetic Disorders
5.1.1.4 Successful Completion of the Human Genome Project
5.1.2 Restraints
5.1.2.1 Privacy Issues Related to Genetic Information
5.1.2.2 Unfavorable Reimbursement Scenario for Genetic Testing
5.1.3 Opportunities
5.1.3.1 Increased Use of Personalized Medicine
5.1.3.2 Developing Countries Present Significant Opportunities for the Molecular Biology Enzymes and Kits & Reagents Market
5.1.3.3 Shift From Plant-Derived to Genome-Based Drug Discovery
6 Industry Insights
6.1 Porter’s Five Forces Analysis
6.1.1 Bargaining Power of Buyers
6.1.2 Bargaining Power of Suppliers
6.1.3 Threat From New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Competitive Rivalry
7 Global Molecular Biology Enzymes and Kits & Reagents Market, By Product
7.1 Introduction
7.2 Kits and Reagents
7.3 Enzymes
7.3.1 Polymerases
7.3.2 Ligases
7.3.3 Restriction Endonucleases
7.3.4 Reverse Transcriptases
7.3.5 Phosphatases
7.3.6 Proteases and Proteinases
7.3.7 Other Enzymes
8 Global Molecular Biology Enzymes and Kits & Reagents Market, By Application
8.1 Introduction
8.2 Polymerase Chain Reaction (PCR)
8.3 Sequencing
8.4 Cloning
8.5 Epigenetics
8.6 Restriction Digestion
8.7 Synthetic Biology
8.8 Other Applications
9 Molecular Biology Enzymes and Kits & Reagents Market, By End User
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Hospitals & Diagnostic Centers
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users
10 Molecular Biology Enzymes and Kits & Reagents Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Increasing Research Funding for Genomics Research
10.2.1.2 Rising Number of Pharmaceutical and Biotechnology Companies Likely to Boost Sales of Molecular Biology Enzymes, Kits, Reagents
10.2.1.3 Increasing Prevalence of Conditions Involving Molecular Diagnostics, Backed By Reimbursement
10.2.2 Canada
10.2.2.1 Investments in Research Projects
10.3 Europe
10.3.1 Germany
10.3.1.1 Presence of A Large Number of Academic and Research Institutes
10.3.1.2 Venture Capital Investments in Germany
10.3.2 U.K.
10.3.2.1 Funding for Research Activities
10.3.2.2 Increasing Adoption of Molecular Diagnostics for Cancer Diagnosis in the U.K.
10.3.3 France
10.3.3.1 Presence of Large Patient Pool for Cancer
10.3.4 RoE
10.3.4.1 Presence of Large Number of Pharmaceutical and Biotechnology Companies
10.4 Asia-Pacific
10.4.1 China
10.4.1.1 Increasing Government Interest in Biomedical and Biotechnology Industries
10.4.1.2 Presence of Bio-Clusters in China
10.4.1.3 Outsourcing of Clinical Research Activities to China
10.4.2 Japan
10.4.2.1 Conferences and Meetings to Propel the Japanese Market
10.4.2.2 Rising Research Funding and Growing Geriatric Population
10.4.3 India
10.4.3.1 Growing Pharmaceutical Industry in India Backed By Government Initiatives to Drive The Growth for Molecular Biology Kits Market
10.4.3.2 Development of Bio-Clusters to Propel the Biotechnology Industry in India
10.4.4 Roapac
10.4.4.1 Korea-U.S. Free Trade Agreement (Korus)
10.4.4.2 Initiatives By Non-Profit Organizations
10.4.4.3 Alliances and Partnerships in Molecular Biology Application Areas to Boost Australian Molecular Biology Kits Market
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Investments in Research & Innovation Centers and Conferences & Workshops in Brazil
10.5.2 Middle East and Africa
10.5.2.1 Rising Prevalence of Conditions Involving Molecular Diagnostics in Africa
10.5.2.2 Conferences in the Middle East and Africa
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.2.2 Thermo Fisher Scientific, Inc.
11.2.3 Merck KGAA
11.2.4 Others
11.3 Competitive Situation and Trends
11.3.1 New Product Launches
11.3.2 Agreements, Alliances, Partnerships and Collaboration
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Others
12 Company Profiles
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.3 Merck KGAA
12.4 Promega Corporation
12.5 New England Biolabs, Inc.
12.6 Illumina, Inc.
12.7 Takara Bio Inc.
12.8 Qiagen N.V.
12.9 Agilent Technologies, Inc.
12.10 F. Hoffmann-La Roche Ltd
12.11 Becton, Dickinson and Company
The Molecular Biology Enzymes and Kits & Reagents Market has been segmented as below: (Accordingly)
By Application Analysis:
By Product Analysis:
By End User Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
